Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Overview
- Macroeconomic Factors
- Impact of U.S. Tariffs on the Pharmaceutical and Medical Device Industries
- Population Demographics and Aging Populations
- Healthcare Infrastructure and Spending
- Regulatory and Policy Landscape
- Technological Advances and Funding
- Geopolitical Risks, Trade Wars, and Supply Chain Disruptions
- Porter’s Five Forces Analysis
- Potential for New Entrants (Moderate to High)
- Bargaining Power of Suppliers (Low to Moderate)
- Bargaining Power of Buyers (Moderate to High)
- Threat of Substitute Products or Services (High)
- Industry Level of Competitiveness (Moderate to High)
Chapter 3 Market Dynamics
- Overview
- Market Drivers
- Increasing Incidence of Needlestick Injuries
- Preference for Painless Drug Delivery
- Demand for Home Healthcare and Self-Administration
- Market Restraints
- Cost of Needle-Free Technology
- Limitations of Large Volume and Intravenous Administration Systems
- Market Opportunities
- Product Innovation
- Increased Investments in Healthcare in Emerging Markets
Chapter 4 Regulatory Landscape
- Overview
- Regulatory Scenario in the U.S.
- Regulatory Scenario in Europe
- Regulatory Scenario in Japan
- Regulatory Scenario in China
- FDA-Approved Inhalers
- FDA-Approved Transdermal Patch
Chapter 5 Emerging Trends and Pipeline Analysis
- Emerging Trends
- Smart Patches
- Smart Inhalers
- Sonophoresis
- 3D-Printed Microarray Patches
- Dissolving/Degradable Patches
- Pipeline Analysis
- Takeaways
- Patent Analysis
- Inhaler Technologies
- Transdermal Patches
- Needle-Free Injectors
- Findings
Chapter 6 Market Segmentation Analysis
- Segmentation Breakdown
- Market Breakdown by Product Type
- Takeaways
- Inhaler Technologies
- Transdermal Patches
- Needle-free Injectors
- Other Novel Technologies
- Market Breakdown by Application
- Takeaways
- Vaccines
- Pain Management
- Insulin Delivery
- Pediatric Drug Delivery
- Other Applications
- Market Breakdown by End-User
- Takeaways
- Hospital and Clinics
- Homecare Settings
- Research and Academic Institutions
- Geographic Breakdown
- Market Breakdown by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- South America
- Middle East and Africa
Chapter 7 Competitive Intelligence
- Takeaways
- Market Shares of Leading Companies
- Strategic Analysis
Chapter 8 Sustainability in Needle-Free Devices: ESG Perspective
- Overview
- Environmental Sustainability
- Social Responsibility
- Governance Perspective
- ESG Risk Ratings
- Concluding Remarks
List of Tables
Summary Table: Global Market for Needle-Free Devices, by Region, Through 2030
Table 1: FDA Device Classifications
Table 2: Approved Inhalers
Table 3: FDA-Approved Transdermal Products
Table 4: Pipeline Drugs for Needle-Free Devices
Table 5: Granted Patents for Inhaler Technologies, 2022-2025
Table 6: Granted Patents for Transdermal Patches, 2022-2025
Table 7: Granted Patents for Needle-Free Injectors, 2022-2025
Table 8: Global Market for Needle-Free Devices, by Product Type, Through 2030
Table 9: Global Market for Inhaler Technologies, by Type, Through 2030
Table 10: Global Market for Inhaler Technologies, by Region, Through 2030
Table 11: Drug Used in Transdermal Patches/Products
Table 12: Global Market for Transdermal Patches, by Region, Through 2030
Table 13: Comparison of the Three Medication Types of Needle-Free Injectors
Table 14: Global Market for Needle-free Injectors, by Medication Type, Through 2030
Table 15: Global Market for Needle-free Injectors, by Drug Delivery, Through 2030
Table 16: Global Market for Needle-free Injectors, by Region, Through 2030
Table 17: Global Market for Other Novel Needle-free Technologies, by Region, Through 2030
Table 18: Global Market for Needle-Free Devices, by Application, Through 2030
Table 19: Global Market for Needle-Free Devices, by End User, Through 2030
Table 20: Global Market for Needle-Free Devices, by Region, Through 2030
Table 21: North American Market for Needle-Free Devices, by Product Type, Through 2030
Table 22: North American Market for Needle-Free Devices, by Country, Through 2030
Table 23: U.S. Market for Needle-Free Devices, by Product Type, Through 2030
Table 24: Canadian Market for Needle-Free Devices, by Product Type, Through 2030
Table 25: Mexican Market for Needle-Free Devices, by Product Type, Through 2030
Table 26: European Market for Needle-Free Devices, by Product Type, Through 2030
Table 27: European Market for Needle-Free Devices, by Country, Through 2030
Table 28: German Market for Needle-Free Devices, by Product Type, Through 2030
Table 29: U.K. Market for Needle-Free Devices, by Product Type, Through 2030
Table 30: French Market for Needle-Free Devices, by Product Type, Through 2030
Table 31: Spanish Market for Needle-Free Devices, by Product Type, Through 2030
Table 32: Italian Market for Needle-Free Devices, by Product Type, Through 2030
Table 33: Rest of European Market for Needle-Free Devices, by Product Type, Through 2030
Table 34: Asia-Pacific Market for Needle-Free Devices, by Product Type, Through 2030
Table 35: Asia-Pacific Market for Needle-Free Devices, by Country, Through 2030
Table 36: Chinese Market for Needle-Free Devices, by Product Type, Through 2030
Table 37: Japanese Market for Needle-Free Devices, by Product Type, Through 2030
Table 38: Indian Market for Needle-Free Devices, by Product Type, Through 2030
Table 39: Rest of Asia-Pacific Market for Needle-Free Devices, by Product Type, Through 2030
Table 40: South American Market for Needle-Free Devices, by Product Type, Through 2030
Table 41: South American Market for Needle-Free Devices, by Country, Through 2030
Table 42: Brazilian Market for Needle-Free Devices, by Product Type, Through 2030
Table 43: Argentine Market for Needle-Free Devices, by Product Type, Through 2030
Table 44: Rest of South American Market for Needle-Free Devices, by Product Type, Through 2030
Table 45: MEA Market for Needle-Free Devices, by Product Type, Through 2030
Table 46: MEA Market for Needle-Free Devices, by Subregion, Through 2030
Table 47: Middle East Market for Needle-Free Devices, by Product Type, Through 2030
Table 48: African Market for Needle-Free Devices, by Product Type, Through 2030
Table 49: Recent Developments in the Needle-free Device Industry
Table 50: ESG Risk Rankings for Needle-Free Device Companies, 2024*
Table 51: Information Sources Used in this Report
Table 52: Abbreviations Used in this Report
Table 53: Akra Dermojet: Company Snapshot
Table 54: Akra Dermojet: Product Portfolio
Table 55: AptarGroup Inc.: Company Snapshot
Table 56: AptarGroup Inc.: Financial Performance, FY 2023 and 2024
Table 57: AptarGroup Inc.: Product Portfolio
Table 58: AptarGroup Inc.: News/Key Developments, 2022-2024
Table 59: ARx LLC.: Company Snapshot
Table 60: ARx LLC: Product Portfolio
Table 61: AstraZeneca: Company Snapshot
Table 62: AstraZeneca: Financial Performance, FY 2023 and 2024
Table 63: AstraZeneca: Product Portfolio
Table 64: AstraZeneca: News/Key Developments, 2023 and 2024
Table 65: aVaxziPen: Company Snapshot
Table 66: aVaxziPen: Product Portfolio
Table 67: aVaxziPen: News/Key Developments, 2024
Table 68: CROSSJECT: Company Snapshot
Table 69: CROSSJECT: Financial Performance, FY 2023 and 2024
Table 70: CROSSJECT: Product Portfolio
Table 71: CROSSJECT: News/Key Developments, 2023-2025
Table 72: Endo Inc.: Company Snapshot
Table 73: Endo Inc.: Financial Performance, FY 2023 and 2024
Table 74: Endo Inc.: Product Portfolio
Table 75: Endo Inc.: News/Key Developments, 2025
Table 76: GSK plc.: Company Snapshot
Table 77: GSK Plc.: Financial Performance, FY 2023 and 2024
Table 78: GSK Plc.: Product Portfolio
Table 79: GSK Plc.: News/Key Developments, 2025
Table 80: Halozyme Inc.: Company Snapshot
Table 81: Halozyme Inc.: Financial Performance, FY 2023 and 2024
Table 82: Halozyme Inc.: Product Portfolio
Table 83: Halozyme Inc.: News/Key Developments, 2023-2025
Table 84: MIKA MEDICAL CO.: Company Snapshot
Table 85: MIKA MEDICAL CO: Product Portfolio
Table 86: Novartis AG: Company Snapshot
Table 87: Novartis AG: Financial Performance, FY 2023 and 2024
Table 88: Novartis AG: Product Portfolio
Table 89: Novartis AG: News/Key Developments, 2020
Table 90: NuGen Medical Devices: Company Snapshot
Table 91: NuGen Medical Devices: Financial Performance, FY 2023 and 2024
Table 92: NuGen Medical Devices: Product Portfolio
Table 93: NuGen Medical Devices: News/Key Developments, 2023-2025
Table 94: PharmaJet: Company Snapshot
Table 95: PharmaJet: Product Portfolio
Table 96: PharmaJet: News/Key Developments, 2023-2024
Table 97: Presspart Verwaltungs GmbH: Company Snapshot
Table 98: Presspart Verwaltungs GmbH: Product Portfolio
Table 99: Presspart Verwaltungs GmbH.: News/Key Developments, 2023 and 2024
Table 100: Viatris Inc.: Company Snapshot
Table 101: Viatris Inc.: Financial Performance, FY 2023 and 2024
Table 102: Viatris Inc.: Product Portfolio
Table 103: Viatris Inc.: News/Key Developments, 2022
Table 104: Emerging Startups
List of Figures
Summary Figure: Global Market Shares of Needle-Free Devices, by Region, 2024
Figure 1: Porter’s Five Forces Analysis
Figure 2: Market Dynamics of Needle-Free Devices
Figure 3: Needlestick Injuries in Hospitals, by Department
Figure 4: Patents for Inhaler Technologies, 2022-2025
Figure 5: Patents for Transdermal Patches, 2022-2025
Figure 6: Patents for Needle-Free Injectors, 2022-2025
Figure 7: Global Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 8: Global Market Shares of Inhaler Technologies, by Region, 2024
Figure 9: Global Market Shares of Transdermal Patches, by Region, 2024
Figure 10: Global Market Shares of Needle-free Injectors, by Region, 2024
Figure 11: Global Market Shares of Other Novel Needle-free Technologies, by Region, 2024
Figure 12: Global Market Shares of Needle-Free Devices, by Application, 2024
Figure 13: Global Market Shares of Needle-Free Devices, by End User, 2024
Figure 14: Global Market Shares of Needle-Free Devices, by Region, 2024
Figure 15: North American Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 16: North American Market Shares of Needle-Free Devices, by Country, 2024
Figure 17: U.S. Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 18: Canadian Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 19: Mexican Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 20: European Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 21: European Market Shares of Needle-Free Devices, by Country, 2024
Figure 22: German Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 23: U.K. Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 24: French Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 25: Spanish Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 26: Italian Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 27: Rest of European Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 28: Asia-Pacific Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 29: Asia-Pacific Market Shares of Needle-Free Devices, by Country, 2024
Figure 30: Chinese Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 31: Japanese Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 32: Indian Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 33: Rest of Asia-Pacific Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 34: South American Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 35: South American Market Shares of Needle-Free Devices, by Country, 2024
Figure 36: Brazilian Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 37: Argentine Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 38: Rest of South American Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 39: MEA Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 40: MEA Market Shares of Needle-Free Devices, by Subregion, 2024
Figure 41: Middle East Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 42: African Market Shares of Needle-Free Devices, by Product Type, 2024
Figure 43: Needle-Free Device Makers Global Market Shares, 2024
Figure 44: AptarGroup Inc.: Revenue Share, by Business Unit, FY 2024
Figure 45: AptarGroup Inc.: Revenue Share, by Region/Country, FY 2024
Figure 46: ASTRAZENECA: Revenue Share, by Business Unit, FY 2024
Figure 47: ASTRAZENECA: Revenue Share, by Region/Country, FY 2024
Figure 48: Endo Inc.: Revenue Share, by Business Unit, FY 2024
Figure 49: GSK Plc.: Revenue Share, by Business Unit, FY 2024
Figure 50: GSK Plc.: Revenue Share, by Country/Region, FY 2024
Figure 51: Halozyme Inc.: Revenue Share, by Business Unit, FY 2024
Figure 52: Halozyme Inc.: Revenue Share, by Country/Region, FY 2024
Figure 53: Novartis AG: Revenue Share, by Business Unit, FY 2024
Figure 54: Novartis AG: Revenue Share, by Country/Region, FY 2024
Figure 55: Viatris Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 56: Viatris Inc.: Revenue Shares, by Country/Region, FY 2024
